HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome.

Abstract
Wolcott-Rallison syndrome (WRS) is a very rare genetic disorder, which is transmitted by autosomal recessive inheritance and results from mutations in the gene encoding the eukaryotic initiation factor 2-α kinase-3 (EIF2AK3). The cardinal features of the syndrome include early-onset insulin-dependent diabetes mellitus, multiple epiphyseal dysplasia, and growth retardation. We present the case of a 13-year-old Greek boy with a known history of infancy-onset diabetes mellitus and was found to have WRS at the age of 4 years. He presented with acute liver and renal insufficiency in addition to skeletal dysplasia and neurodevelopmental retardation. The clinical suspicion of WRS was confirmed by molecular analysis of the EIF2AK3 gene. The patient was found to be a compound heterozygote with two different novel mutations (c.2776C>T, p.R902X and c.3038A>G, p.Y989C). The current patient is one of the longer survivors.
AuthorsPanagiota Triantafyllou, Euthymia Vargiami, Isidora Vagianou, Maria Badouraki, Cecile Julier, Dimitrios I Zafeiriou
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 27 Issue 9-10 Pg. 967-70 (Sep 2014) ISSN: 2191-0251 [Electronic] Germany
PMID24859506 (Publication Type: Case Reports, Journal Article)
Chemical References
  • eIF-2 Kinase
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 (diagnosis, genetics)
  • Epiphyses (abnormalities)
  • Humans
  • Male
  • Mutation
  • Osteochondrodysplasias (diagnosis, genetics)
  • eIF-2 Kinase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: